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Abstract
Background: Pallister-Killian syndrome (PKS) is a sporadic genetic disorder caused by the presence of a tissue-specific
mosaicism for isochromosome 12p - i(12) (p10) and is characterized by facial dysmorphism including coarse facies,
upslanting palpebral fissures, bitemporal alopecia, pigmentary skin anomalies, developmental delay, hypotonia and
seizures. Although typical clinical features of PKS commonly exist, clinicians often do not raise the possibility of this
diagnosis.
Results: We reviewed the medical records of 10 patients with confirmed PKS followed in our service (since 1990 to
2015). Age at diagnosis varied from prenatal to 3 years and clinical features were consistent with those described in
the literature. In all patients, peripheral blood karyotypes were normal and cytogenomic study was performed in order
to confirm the diagnosis. Three of these patients had PKS diagnosis confirmed by buccal smear MLPA.
Conclusion: An early conclusion from our results demonstrated that MLPA on buccal smears is a good and non-invasive
method to detect extra copies of 12p and should be considered as the first exam, before a skin biopsy for a fibroblast
karyotype is performed.
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Background
Pallister-Killian syndrome (PKS) is a sporadic and rare
chromosomal disorder caused by the mosaicism for
isochromosome 12p – i(12)(p10). There are just over
200 cases described in the literature [1]. The syndrome is
known by several names, such as Pallister mosaic syndrome,
Pallister-Killian syndrome, Pallister-Killian-Teschler-Nicola
syndrome, tetrasomy 12p and isochromosome 12p [2, 3].
Clinical findings of PKS are distinctive, especially the
combination of coarse facies, pigmentary skin anomalies,
developmental delay, hypotonia and seizures. The facial
appearance includes coarse facies (coarseness becomes
more pronounced with age), prominent forehead, hyperte-
lorism, upslanting palpebral fissures with epicanthal folds,
small nose with upturned nares, high arched palate,
macrostomia, long philtrum, micrognathia, bitemporal
alopecia and an extension of the philtral skin into the
vermilion border of the upper lip, which is termed
“Pallister lip”. Other associated findings include the
following: congenital heart defects, diaphragmatic hernia,
cryptorchidism, renal malformations, imperforate or
anteriorly placed anus [2–4]. Patients have hypotonia,
mental and motor retardation from early infancy, which
can vary from mild to severe and profound [2, 5–7].
PKS is caused by a tissue-limited mosaicism for super-
numerary i(12)(p10) [4, 8]. Although different levels of
mosaicism and genetic variation in isochromosome
composition have already been described in the literature,
there is currently no evidence for genotype-phenotype
correlation [3].
A fibroblast karyotype from skin biopsy is commonly
used to achieve PKS diagnosis, but other tissues such as
lung, tissue from a buccal smear, bone marrow and even
amniotic fluid yield higher percentages of mosaicism
i(12)(p10), which can help diagnose PKS [9–11].
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Results
All ten patients had PKS confirmed by a fibroblast or
amniotic fluid karyotype or by buccal smear MLPA. The
presence of i(12)(p10) in the fibroblast karyotype ranged
from 50 % to 100 % and in amniotic fluid from 75 % to
100 % (Table 1).
Peripheral blood karyotypes were normal in nine
patients. In one who died at 5 days of age it was not
performed but diagnosis was confirmed by amniotic
fluid karyotype.
Three patients, with clinical features of PKS, had
buccal smear MLPA confirming the diagnosis. In two
patients fibroblasts culture failed and MLPA was per-
formed in buccal smear sample showing four copies
of the short arm of chromosome 12 (Fig. 1). In another
patient, who had fibroblast karyotype, it was also per-
formed MLPA of buccal smear and fibroblast in order to
confirm that MLPA was able to diagnosis PKS.
Clinical aspects are shown in Table 2. All patients pre-
sented clinical features associated with PKS (Fig. 2). Two
of these patients were previously described [12]. Age at
diagnosis varied from the prenatal period to 1y10mo.
Two patients died: one at 5 days due to respiratory
problems and other at 14 years old due to pneumonia.
Two patients have lost follow-up.
Current age of six patients ranges from 1y9mo to
19 years.
Discussion
Although typical clinical features of PKS commonly
exist, clinicians often do not raise the possibility of this
diagnosis. Another factor that makes this diagnosis diffi-
cult is the need for cytogenetic analysis of tissues other
than peripheral blood.
Even though there is no pathognomonic feature of
PKS, there are some typical findings such as coarse
facies, prominent forehead, bitemporal alopecia, upslanting
palpebral fissures, cleft palate, sparse eyebrows, pigmentary
skin anomalies including hyperpigmented and hypopig-
mented streaks, developmental delay, hypotonia and
seizures. It is important to note that some of these
findings might not be evident at birth; the coarsening
of the face occurs as the child ages [2].
All patients described in our study exhibited typical
clinical features of PKS, and parental age at conception
was in accordance with that reported in the literature [3].
Cardiac malformations are common in PKS patients
described in the literature; the most common malforma-
tions are patent foramen ovale, atrial septal defects and
patent ductus arteriosus [3, 13]. Two of our patients had
aneurysm of the interatrial septum, which had not been
previously described in PKS.
Skin anomalies, such as hyperpigmented and hypopig-
mented streaks, were observed in 6/10 patients. Despite
being a frequent finding in PKS patients, such skin
anomalies are considered suggestive of PKS and not a
mandatory feature.
With regard to the ophthalmological findings, one patient
had a diffuse abnormality of retina pigmentation, which has
been previously described by Graham et al. This may sug-
gest a retinal pigment mosaicism similar to that described
in skin [14].
Gastrointestinal malformations were found less fre-
quently in our cohort than described in the literature,
although the malformations were similar to those previously
described: displacement of the anus and umbilical hernia.
Diaphragmatic hernias, present in 11–29 % of reported
cases, were not observed in our patients [3].
Table 1 Results of karyotype, MLPA (according to ISCN, 2013) and age at diagnosis
Cases Results % cells with i12p Tissue Age at diagnosis
1 47,XX,+i(12)(p10)/46,XX 82 Skin 3mo 24 d
2 47,XX,+i(12)(p10)/46,XX 50 Skin 10mo
3 47,XX,+i(12)(p10)/46,XX 80 Skin 1y10mo
4 47,XX,+i(12)(p10) 100 Skin 1y5mo
6 47,XX,+i(12)(p10)/46,XX 75 Amniotic fluid Prenatal
47,XX,+i(12)(p10) 100 Skin 2y 4 mo
MLPA rsa 12p13.3(RBBP2)X4 and
rsa 12p13.3(SLC6A12)X4
NA Buccal smear 2y 4 mo
MLPA rsa 12p13.3(RBBP2)X4 and
rsa 12p13.3(SLC6A12)X4
NA Skin 2y 4 mo
7 47,XY,+i(12)(p10)/46, XY 87 Skin 7 mo
8 47,XY,+i(12)(p10) 100 Skin 3 y
9 47,XY,+i(12)(p10) 100 Amniotic fluid Prenatal
10 MLPA rsa 12p13.3(RBBP2)X4 and
rsa 12p13.3(SLC6A12)X4
NA Buccal Smear 1 y 10 mo
NA - not applicable.
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Hearing and ophthalmologic impairment were observed
less frequently in our population compared to reports in
the literature. Only one patient had bilateral hip dislocation.
Compared to the literature, seizures were observed less
frequently in our cohort. Because the onset of seizures in
PKS patients might occur between the ages of 2 to 5 years,
some of our patients might develop seizures later in life.
There is no typical seizure pattern in PKS patients [15–17].
Similar to our findings, karyotypes of peripheral blood
are usually normal. Wenger et al. showed that only 3 %
of cells from peripheral blood exhibited i(12)(p10),
whereas analysis of skin and lung tissues that were
obtained postmortem exhibited i(12)(p10) in 98.5 %
and 97.5 % of the cells, respectively [9]. Liehr et al.
described a variety of PKS’s karyotypes: complete trisomy
12 inmosaicism: 47,XX,+12[20 %]/47,XX,+i(12)(p10)[80 %],
hexasomy 12p: 48,XX,+i(12)(p10),+i(12)(p10)[16 %], even
when PKS phenotype is typical [18]. More studies are
necessary to stablish if there is a clinical correlation with
the cytogenetics findings.
We used MLPA method for diagnosis with DNA pre-
pared from buccal smear samples in three patients, with
the detection of four copies of the short arm of
chromosome 12, confirming the diagnosis of PKS. There
are few reports of PKS diagnosis using MLPA and DNA
from buccal smears in the literature. We recommend
this analysis as the first exam, before a skin biopsy.
MLPA assay is a recently developed technique that is
able to detect variations in the genes copy number and
dosage. This test is a high throughput analysis, allowing
up to 96 samples to be handled simultaneously allow-
ing the study of several regions of the human genome in
a single reaction [19, 20].
Due to this capability, MLPA can be applied in the
molecular diagnosis of several syndromes since the
duplication of entire genomic regions causes a disease
due to the presence of extra copies of the genes, while
complete or partial deletion can produce a completely
different phenotypic effect [19].
In fact, MLPA assay is one of the most widely used
techniques for the molecular investigation of microdeletion/
microduplication syndromes. The use of this technique has
important advantages such as relative simplicity of
approach, low cost, rapid turnaround, ease of multiplexing
to permit high confidence in the results, high accuracy of
copy number estimation, and the potential for combination
Fig. 1 a and b: Histogram showing MLPA analysis of DNA from buccal smear; c: FISH in interphase cells showing 12p specific subtelomeric probe
(Aquarius®, Cytocell Cambridge, UK ) hybridization; d: Fibroblast skin karyotype showing isochromosome 12p in G band
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Table 2 Clinical features (Continued)
8 Male 31y/NA Upslanting palpebral
fissures, ptosis, epicanthal
folds, flat, broad nasal

















9 Male 16y/NA Hypertelorism,
broad nasal root,















































of copy number analysis with other applications, such as
methylation detection or SNP genotyping [19, 20].
MLPA use target sequences, between 50–80 nucleotides,
that applied to DNA extracted from a buccal swab allow
identifying genomic aberrations, easier than detected by
FISH. Over 300 kits are so far commercially available,
dedicated to the study of several diseases [19].
Finally compared to array CGH (Comparative Genomic
Hybridization) and FISH (Fluorescent In situ Hybridization)
whose have been previously described as alternatives to
diagnose PKS, MLPA technique is less expensive and
technically uncomplicated method [19].
MLPA on buccal smears is also non-invasive and
yields a shorter turnaround time for results compared
to a fibroblast karyotype. A limitation of MLPA is that
mosaicism in low level may not be detected, so a normal
MLPA result cannot rule out PKS diagnosis [20].
Conclusion
A precocious PKS diagnosis is important to optimally
manage the disease and to provide genetic counseling.
MLPA on buccal smears is a good and non-invasive
method to detect extra copies of 12p and should be
considered as the first exam, before a skin biopsy for
a fibroblast karyotype is performed.
Thus we highlight the importance of associate cytoge-
nomic approaches in clinical genetics, to provide additional
information relevant to confirm the diagnosis, for patient
management and genetic counseling.
Methods and patients
This is a descriptive study based on the medical records of
ten patients with a confirmed diagnosis of PKS who were
followed in the Genetics Unit of the Instituto da Criança
(Brazil) from 1990 to 2014. The study was approved by
the by the ethics committee of the HCFMUSP (University
of São Paulo-CAPPesq) and informed consent form was
obtained from all families.
Cytogenomic analysis
Peripheral blood karyotype was performed using a standard
phytohemagglutinin-stimulated lymphocyte culture method
followed by G-banding. Twenty metaphase cells were ana-
lyzed for all patients except one, who died at 5 days of age.
Also, we performed a skin biopsy for fibroblast karyotype
and the long-term closed flask fibroblast explant cultures
were set up according to the protocol adapted from Rooney
[21]. Additional Fluorescence in situ hybridization (FISH)
with chromosome 12p specific subtelomeric probe
(Aquarius®, Cytocell Cambridge, UK) according to the tech-
nique of Pinkel [22], with minor modifications was carried
out on interphase nuclei of subcultured fibroblasts.
In three of the patients buccal smear was collected
with the Oragene Kit (Ottawa, Canada) and DNA was
extracted using the QIAamp DNA Blood Midi Kit
250 (QIAGEN, Valencia, California) in order to perform
Multiplex Ligation-dependent Probe Amplification (MLPA-
MRC Holland, Amsterdam, The Netherlands) assay.
MLPA with kits SALSA P070 and SALSA P036 that
contain subtelomeric probes, RBBP2 and SLC6A12
respectively, determine the DNA copy number variations
in 12p region and can provide a definitive diagnosis.
Consent
Written informed consent was obtained from the parents
of the patients.
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Fig. 2 Patient # 5: dysmorphic features described in PKS:
frontotemporal alopecia, hypertelorism, anteverted nostrils, long
philtrum with “Pallister lip”, hypopigmented streaks. a: frontal view;
b: lateral view
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